Pharmacokinetics of 400 mg of raltegravir once daily in combination with atazanavir/ritonavir plus two nucleoside/nucleotide reverse transcriptase inhibitors.

Autor: Calcagno A, Tettoni MC, Simiele M, Trentini L, Montrucchio C, D'Avolio A, Di Perri G, Bonora S
Zdroj: Journal of Antimicrobial Chemotherapy (JAC); Feb2013, Vol. 68 Issue 2, p482-484, 3p
Databáze: Complementary Index